Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-021491
Filing Date
2025-02-14
Accepted
2025-02-14 17:25:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3724
  Complete submission text file 0000950170-25-021491.txt   5317
Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Howton David T (Reporting) CIK: 0001529297 (see all company filings)

Type: 144

Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Subject) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38360 | Film No.: 25631132
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)